88
Views
24
CrossRef citations to date
0
Altmetric
Original Research

Surface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis

, , , , &
Pages 1959-1968 | Published online: 13 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Han Li, Yinan Ding, Jiayan Huang, Yanyan Zhao, Wei Chen, Qiusha Tang, Yanli An, Rong Chen & Chunmei Hu. (2023) Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis. International Journal of Nanomedicine 18, pages 489-503.
Read now
Firdos Alam Khan, Dana Almohazey, Munthar Alomari & Sarah Ameen Almofty. (2018) Impact of nanoparticles on neuron biology: current research trends. International Journal of Nanomedicine 13, pages 2767-2776.
Read now
Emilia Barcia, Liudmila Boeva, Luis García-García, Karla Slowing, Ana Fernández-Carballido, Yaquelyn Casanova & Sofía Negro. (2017) Nanotechnology-based drug delivery of ropinirole for Parkinson’s disease. Drug Delivery 24:1, pages 1112-1123.
Read now

Articles from other publishers (21)

Pramod Kumar, Aradhana Dwivedi, Kitiporn Plaimas, Kalpana Sagar & Lakshita Chauhan. 2023. Emerging Nanotechnologies for Medical Applications. Emerging Nanotechnologies for Medical Applications 55 94 .
Naumih M. Noah & Peter M. Ndangili. 2023. Polymeric Nanosystems. Polymeric Nanosystems 723 759 .
Simisola Ayodele, Pradeep Kumar, Armorel van Eyk & Yahya E. Choonara. 2023. Tubercular Drug Delivery Systems. Tubercular Drug Delivery Systems 261 287 .
Nicola Paccione, Mahdieh Rahmani, Emilia Barcia & Sofía Negro. (2022) Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems. Pharmaceutics 15:1, pages 13.
Crossref
Mario Alonso-González, Ana Fernández-Carballido, Prissila Quispe-Chauca, Irene Lozza, Cristina Martín-Sabroso & Ana Isabel Fraguas-Sánchez. (2022) DoE-based development of celecoxib loaded PLGA nanoparticles: In ovo assessment of its antiangiogenic effect. European Journal of Pharmaceutics and Biopharmaceutics 180, pages 149-160.
Crossref
Mario Alonso, Emilia Barcia, Juan-Francisco González, Consuelo Montejo, Luis García-García, Mónica-Carolina Villa-Hermosilla, Sofía Negro, Ana-Isabel Fraguas-Sánchez & Ana Fernández-Carballido. (2022) Functionalization of Morin-Loaded PLGA Nanoparticles with Phenylalanine Dipeptide Targeting the Brain. Pharmaceutics 14:11, pages 2348.
Crossref
Yaquelyn Casanova, Sofía Negro, Karla Slowing, Luis García-García, Ana Fernández-Carballido, Mahdieh Rahmani & Emilia Barcia. (2022) Micro- and Nano-Systems Developed for Tolcapone in Parkinson’s Disease. Pharmaceutics 14:5, pages 1080.
Crossref
Srinivas Reddy Jitta & Lalit Kumar. 2022. Nanocarriers for Drug-Targeting Brain Tumors. Nanocarriers for Drug-Targeting Brain Tumors 269 297 .
Chang Sun, Xiaoying Zhang, Jialu Wang, Yahao Chen & Cunren Meng. (2021) Novel mesoporous silica nanocarriers containing gold; a rapid diagnostic tool for tuberculosis. BMC Complementary Medicine and Therapies 21:1.
Crossref
Omar A. Ahmed-Farid, Mohamed Taha, Rofanda M. Bakeer, Omyma K. Radwan, Hassan A. M. Hendawy, Ayman S. Soliman & Einas Yousef. (2021) Effects of bee venom and dopamine-loaded nanoparticles on reserpine-induced Parkinson’s disease rat model. Scientific Reports 11:1.
Crossref
Ali Lashkari & Reza Ranjbar. (2021) Nanoparticles and nanoformulated drugs as promising delivery system in treatment of microbial-induced CNS infection: a systematic review of literature. Journal of NeuroVirology 27:4, pages 542-549.
Crossref
Monique Etnea Machado, Priscila de Souza Furtado, Cristina da Costa Bernardes Araújo, Alice Simon, Marcela Cristina de Moraes, Luiz Cláudio Rodrigues Pereira da Silva, Flávia Almada do Carmo, Lucio Mendes Cabral & Plínio Cunha Sathler. (2021) Novel rivaroxaban—loaded poly(lactic-co-glycolic acid)/poloxamer nanoparticles: preparation, physicochemical characterization, in vitro evaluation of time-dependent anticoagulant activity and toxicological profile. Nanotechnology 32:13, pages 135101.
Crossref
Ebenezeri Erasto Ngowi, Yi-Zhen Wang, Lei Qian, Yasmeen Ahmed Saleheldin Hassan Helmy, Bright Anyomi, Tao Li, Meng Zheng, En-She Jiang, Shao-Feng Duan, Jian-She Wei, Dong-Dong Wu & Xin-Ying Ji. (2021) The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Natascha Hartl, Friederike Adams & Olivia M. Merkel. (2020) From Adsorption to Covalent Bonding: Apolipoprotein E Functionalization of Polymeric Nanoparticles for Drug Delivery Across the Blood–Brain Barrier. Advanced Therapeutics 4:1, pages 2000092.
Crossref
Bushra Nabi, Saleha Rehman, Sumit Aggarwal, Sanjula Baboota & Javed Ali. (2020) Nano-based anti-tubercular drug delivery: an emerging paradigm for improved therapeutic intervention. Drug Delivery and Translational Research 10:4, pages 1111-1121.
Crossref
Ana I. Fraguas-Sánchez, Ana I. Torres-Suárez, Marie Cohen, Florence Delie, Daniel Bastida-Ruiz, Lucile Yart, Cristina Martin-Sabroso & Ana Fernández-Carballido. (2020) PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment. Pharmaceutics 12:5, pages 439.
Crossref
Josef Jampílek & Katarína Kráľová. 2020. Nanoformulations in Human Health. Nanoformulations in Human Health 469 502 .
Sachin Paudel, Constantin Cerbu, Carlos E. Astete, Stacey M. Louie, Cristina Sabliov & Debora F. Rodrigues. (2019) Enrofloxacin-Impregnated PLGA Nanocarriers for Efficient Therapeutics and Diminished Generation of Reactive Oxygen Species. ACS Applied Nano Materials 2:8, pages 5035-5043.
Crossref
Ekaterina Kulchavenya, Kurt G. Naber & Truls Erik Bjerklund Johansen. 2019. Extrapulmonary Tuberculosis. Extrapulmonary Tuberculosis 1 14 .
Kiran Patil, Shashikant Bagade, Smita Bonde, Sanjay Sharma & Gaurav Saraogi. (2018) Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities. Biomedicine & Pharmacotherapy 99, pages 735-745.
Crossref
Pooja Singh, Afsal Kolloli & Selvakumar Subbian. 2018. Understanding the Host Immune Response Against Mycobacterium tuberculosis Infection. Understanding the Host Immune Response Against Mycobacterium tuberculosis Infection 67 97 .